Companies: 10,795·Total market cap: $144.5T
Bloomios, Inc.

Bloomios, Inc.

BLMSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$6447
P/E Ratio
52W High$0.0001
52W Low$0.0001

Bloomios, Inc. (BLMS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

blms · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Bloomios, Inc. (BLMS) measures how much investors pay for each dollar of the company's trailing earnings. BLMS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1.04.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
EPS (TTM)
-$1.04
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bloomios, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2002 – 2022 · Annual
PE Ratio (TTM)
5Y Avg 6.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Bloomios, Inc.
Bloomios, Inc.You
BLMS
$0MN/A-$1.04
Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals, Inc.
AIDA
$0M11.14x$0.10
American Scientific Resources, Incorporated
American Scientific Resources, Incorporated
ASFX
$0MN/A
CEN Biotech, Inc.
CEN Biotech, Inc.
CENBF
$0MN/A-$0.02
MJ Holdings, Inc.
MJ Holdings, Inc.
MJNE
$0MN/A-$0.07
South American Gold Corp.
South American Gold Corp.
SAGD
$0MN/A-$0.00
SES Solar Inc.
SES Solar Inc.
SESI
$0MN/A-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 11 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-1.04
2021-12-31
FY2021
$-0.16
2020-12-31
FY2020
$-0.09
2020-01-31
FY2020
$-0.00
2019-01-31
FY2019
$-0.00
2007-01-31
FY2007
$-0.21
2006-01-31
FY2006
6.87x$1.31
2005-01-31
FY2005
$-4.34
2004-06-30
FY2004
$0.00
2003-06-30
FY2003
$-0.04

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Bloomios, Inc. (BLMS) measures how much investors pay for each dollar of the company's trailing earnings. BLMS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1.04.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$1.04 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

BLMS pe ratio · 6 questions

BLMS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$1.04. Data sourced from Financial Modeling Prep via BLMS's SEC 10-K and 10-Q filings.

BLMS PE ratioWhat is BLMS PE ratioCurrent PE ratio of BLMSBLMS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bloomios, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09